| 000 | 01540 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517230057.0 | ||
| 264 | 0 | _c20181005 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1432-1076 | ||
| 024 | 7 |
_a10.1007/s00431-018-3205-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWheeler, Mark D | |
| 245 | 0 | 0 |
_aA 26-week, randomized trial of insulin detemir versus NPH insulin in children and adolescents with type 2 diabetes (iDEAt2). _h[electronic resource] |
| 260 |
_bEuropean journal of pediatrics _cOct 2018 |
||
| 300 |
_a1497-1503 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aInsulin Detemir _xadverse effects |
| 650 | 0 | 4 |
_aInsulin, Isophane _xadverse effects |
| 650 | 0 | 4 | _aLife Style |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xtherapeutic use |
| 700 | 1 | _aBarrientos-Perez, Margarita | |
| 700 | 1 | _aLo, Fu-Sung | |
| 700 | 1 | _aLiang, Bo | |
| 700 | 1 | _aLunsford, Alison | |
| 700 | 1 | _aThórisdóttir, Ólöf | |
| 700 | 1 | _aZuckerman-Levin, Nehama | |
| 773 | 0 |
_tEuropean journal of pediatrics _gvol. 177 _gno. 10 _gp. 1497-1503 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00431-018-3205-z _zAvailable from publisher's website |
| 999 |
_c28638514 _d28638514 |
||